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Abstract
Intersectin-long (ITSN-L) contains the invariant Dbl homology (DH) and pleckstrin homology (PH) domain structure characteristic of the
majority of Dbl family proteins. This strict domain topography suggests that the PH domain serves an essential, conserved function in the
regulation of the intrinsic guanine nucleotide exchange activity of the DH domain. We evaluated the role of the PH domain in regulating the
DH domain function of ITSN-L. Surprisingly, we found that the PH domain was dispensable for guanine nucleotide exchange activity on
Cdc42 in vitro, yet the PH domain enhanced the ability of the DH domain to activate Cdc42 signaling in vivo. PH domains can interact with
phosphoinositide substrates and products of phosphatidylinositol 3-kinase (PI3K). However, PI3K activation did not modulate ITSN-L DH
domain function in vivo.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Members of the Dbl family of proteins function as gua-
nine nucleotide exchange factors (GEFs) that activate Rho
family GTPases (reviewed in Refs. [1,2]). Like Ras, Rho
family GTPases function as regulated GDP/GTP switches,
where Dbl family proteins catalyze guanine nucleotide
exchange to promote formation of the active GTP-bound
protein. Upon activation, Rho GTPases (with RhoA, Rac1,
and Cdc42 being the best characterized) interact with a
diverse spectrum of effectors to regulate actin cytoskeletal
organization, gene expression, and cell cycle progression
[3,4].
Mammalian Dbl family proteins now number over 50,
with many identified initially as transforming proteins (e.g.,
Dbl, Vav, Ect2) [1,2]. All Dbl family proteins possess a
catalytic Dbl homology (DH) domain that serves to accel-
erate the intrinsic GDP/GTP exchange activity of Rho
family proteins. In addition to the DH domain, the vast
majority of Dbl family proteins possess a pleckstrin homol-
ogy (PH) domain. Although PH domains are found in other
signaling proteins [5], the invariant positioning of a PH
domain immediately COOH-terminal to the DH domain
supports the notion that the PH domain is a critical mediator
of DH domain function. In support of this possibility,
mutation of the PH domain typically abolishes the trans-
forming activity of Dbl family oncoproteins [1,2].
Current evidence attributes two possible functions to the
PH domain of Dbl family proteins. First, the PH domain
may promote Dbl protein association with the plasma
membrane where Rho GTPase substrates reside. For exam-
ple, the loss of transformation caused by mutation of the
PH domain of Dbs and Lsc can be restored by adding a
plasma membrane-targeting sequence [6,7]. Second, the PH
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domain may be critical for positive or negative modulation
of the intrinsic catalytic activity of the DH domain. A
comparison of the catalytic activity of the DH and DH–PH
domains derived from several Dbl family proteins (e.g.,
Trio, Dbs) showed that the PH-domain-containing protein
exhibited up to 100-fold greater exchange activity than
that measured for the DH domain alone in vitro [8,9].
Conversely, the PH domain of other Dbl family proteins
(Sos, Vav, and Dbl) may actually serve to negatively
regulate DH domain activity, a function that is relieved
by association with phosphoinositides. For example, there
is evidence that products of agonist-stimulated phosphoi-
nositide 3-kinases (PI3Ks), such as phosphatidylinositide
3,4,5-triphosphate (PtdIns(3,4,5)P3), can promote the in
vitro and in vivo activation of the DH domains of Vav
and Sos through PH domain-dependent mechanisms [10,
11]. Thus, PtdIns(3,4,5)P3 association with the PH domain
is thought to facilitate the association of Dbl family proteins
with the plasma membrane or to modulate DH domain
catalytic activity or both. However, the critical structural
determinants required for high-affinity binding to phosphoi-
nositides are absent from the PH domains of Dbl family
proteins [12,13]. Because PH domains significantly vary in
phosphoinositide binding specificity and affinity [14,15], it
is likely that the PH domains of Dbl family proteins will
serve distinct and varied functions with regard to phosphoi-
nositide interactions.
Intersectin (ITSN; also known as Dap-160, EHSH-1, and
Ese-1) was originally identified as an adaptor protein that
contains two Eps 15 homology (EH) domains followed by
five Src homology 3 (SH3) domains [16,17]. Current
evidence supports a function for ITSN in regulation of
endocytosis and mitogenesis [18]. Subsequent studies have
described a long isoform of ITSN (designated ITSN-L) that
is created by alternative RNA splicing and is expressed
primarily in the nervous system [19,20]. ITSN-L is distinct
from the short form (ITSN-S) in that, in addition to the NH2-
terminal EH and SH3 domains, it contains tandem DH and
PH domains followed by a C2 domain at its COOH
terminus. Thus, ITSN-L may function as a GEF for Rho
family small GTPases and this activity may be regulated by
PI3K activation.
We and others recently determined that the ITSN-L DH
domain promotes GDP/GTP exchange on Cdc42, but not
Rac1 or RhoA [21,22]. In addition, we also determined that
the PH domain of ITSN-L binds to a broad spectrum of
phosphoinositides, including PtdIns(3,4,5)P3, at low micro-
molar affinities in vitro [23]. However, phosphoinositide
binding did not regulate the intrinsic catalytic activity of the
DH domain. Finally, our structural analyses of the ITSN-L
DH–PH domain showed that the PH domain is not in
contact with the complexed Cdc42 substrate [24]. This
contrasts with the PH domain of another Dbl family protein,
Dbs, where the PH domain is in contact with bound Cdc42
or RhoA and is required for full DH domain catalytic
activity in vitro [25]. The importance of the PH domain in
ITSN DH domain function in vivo, and whether it is
regulated by PI3K-stimulated phosphoinositides, has not
been determined. In this study, we have analyzed the role
of the PH domain in regulation of ITSN DH domain
function and assessed the contribution of PI3K activation
to its regulation. We found that the PH domain is dispen-
sable for ITSN DH domain activity in vitro but not in vivo,
and that PI3K is not a regulator of ITSN DH domain
function in cells.
2. Materials and methods
2.1. Molecular constructs
A cDNA fragment corresponding to the DH domain of
human ITSN-L (GenBank accession no. AF064244) was
amplified using polymerase chain reaction (PCR). A 5VDH
primer (CTG CGG AAT TCC ATG GCA GAT ATG TTG
ACC CCA ACT GAA) containing EcoRI and NcoI sites and
seven DH domain NH2-terminal residues was used in
conjunction with a 3VDH primer (CGC CTC GAG CTA
CAG GCC TTC ACA CTG CAC GTG) containing an XhoI
site and seven DH COOH-terminal residues to generate a
0.6-kb fragment. To subclone the DH–PH domain frag-
ment, the same 5VDH domain primer was used in conjunc-
tion with a 3VPH primer (CGC CTC GAG CTA CAG GTA
CGC TTT CTC GCG CTT) containing an XhoI site and
seven PH domain COOH-terminal residues to generate a
1.1-kb fragment.
An NheI–BamHI cDNA cassette encoding the NH2-
terminal myristoylation sequence from human lck
(MGCGCSSHPEDD) as well as c-Myc epitope and hepta-
histidine tags were ligated into NheI–BamHI-digested
pcDNA3.1 to create a plasmid, referred to as pTag14, that
contains NH2-terminal myristoylation signal and plasma
membrane targeting sequences to direct localization to the
plasma membrane [26]. ITSN DH and DH–PH PCR
products were digested with EcoRI and XhoI before ligation
in frame with appropriately digested pTag14 plasmid.
Expression of ITSN DH and DH–PH domains was verified
by immunoblotting with anti-Myc monoclonal antibody
(clone 9E10; Roche Molecular Biochemicals).
2.2. Protein purification and guanine nucleotide exchange
assays
cDNA fragments generated as described above were
digested with NcoI and XhoI and ligated into the appropri-
ately digested bacterial expression vector, pET28a (Nova-
gen). The bacterial expression constructs were transformed
into the BL21 (DE3) strain of Escherichia coli and protein
expression and purification were done as standard. A
bacterially expressed glutathione S-transferase (GST) fusion
protein containing sequence of human Cdc42 was purified
as described previously [8]. Fluorescence spectroscopic
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analysis of N-methylanthraniloyl (mant)-GDP incorporation
into GDP-loaded Cdc42 was carried out as described pre-
viously [27].
2.3. Cell culture and transient expression reporter gene
assays
NIH 3T3 cells were seeded onto six-well culture dishes
(1.25 105 cells/well) in growth medium (DMEM sup-
plemented with 10% bovine calf serum), and transient
transfections were performed by calcium phosphate co-
precipitation followed by glycerol shock as previously
described [28]. Twenty-four hours after transfection, cells
were starved of serum for 16 h in DMEM supplemented
with 0.5% calf serum to reduce the level of serum-stimu-
lated activation of serum response factor (SRF). Lysates of
transiently transfected cells were analyzed using enhanced
chemiluminescence reagents using Monolight 2010 lumin-
ometer (Analytical Luminescence) as described previously
[29]. The (SREm)2 reporter plasmid contains a luciferase
gene whose expression is under control of an SRF-respon-
sive promoter as has been previously described [30].
2.4. Subcellular fractionation analyses
NIH 3T3 cells (5 105 cells per 100-mm dish) were
transiently transfected with 1 Ag of pTag14 empty vector or
pTag14 constructs encoding ITSN DH and DH–PH do-
mains. Twenty-four hours after transfection, cells were
starved of serum in DMEM supplemented with 0.5% calf
serum for 16–18 h, washed with ice-cold phosphate-buf-
fered saline, and swelled in HYPO buffer (2 M Tris, pH 7.4,
1 M MgCl2) supplemented with 5 Ag/ml leupeptin, 5 Ag/ml
aprotinin, 5 Ag/ml pepstatin A, and 1 mg/ml phenylmethyl-
sulfonyl fluoride. After 10-min incubation on ice, lysates
were homogenized and 1 M NaCl was added to adjust the
ionic strength to 0.15 M. Lysates (500 Al) were set aside for
the total fraction (T) and the remaining 1-ml volume was
centrifuged at 100,000 g to separate into crude cytosolic
(S) and membrane (P) fractions as described previously
[31]. Proteins in the fractions were precipitated with 5 ml of
acetone for 1 h at 4 jC, collected by centrifugation at 3000
rpm for 30 min, and resuspended in 50 ml (T) or 100 ml (S
and P) of electrophoresis sample buffer. Equal volumes of
each fraction were resolved by SDS-PAGE and protein
expression was determined following transfer to Immobi-
lon-P membranes (Millipore) by immunoblotting with anti-
Myc epitope (clone 9E10; Roche Molecular Biochemicals),
anti-RhoGDI rabbit polyclonal (sc-360; Santa Cruz Bio-
technology), or an anti-pan Ras (OP-40; Oncogene Research
Products) mouse monoclonal antibody.
2.5. Pull-down assay for GTPase activation
ITSN-L-mediated activation of cellular Cdc42 was meas-
ured using a GST:Pak-RBD fusion protein for affinity
purification of GTP-bound Cdc42 as previously described
[22]. Pak-RBD is the fragment of Pak1 that binds pre-
ferentially to GTP-bound Cdc42 and Rac1. Subconfluent
NIH 3T3 cells were transfected with expression plasmids
encoding full-length or the DH–PH domain fragment of
ITSN-L, then starved for 24–48 h in DMEM supplemented
with 0.5% calf serum and lysed in 25 mM HEPES (pH 7.5),
150 mM NaCl, 1% NP-40, 0.25% Na-deoxycholate, 10%
glycerol, 10 mM MgCl2, supplemented with 1 mM PMSF.
Lysates (250–400 Ag) were then incubated with GST:PAK-
RBD immobilized on glutathione beads for 30 min at 4 jC.
The beads were then washed twice in cold lysis buffer and
processed for SDS-PAGE followed by Western blot analy-
ses with an anti-Cdc42 monoclonal antibody (C70820;
Transduction Labs).
3. Results and discussion
3.1. The PH domain is dispensable for DH domain activity
in vitro
We recently showed that the ITSN-L DH–PH is a
Cdc42-specific GEF in vitro and in vivo [22]. However,
the precise contribution of the PH domain to DH domain
function has not been determined. Therefore, we first
compared the activity of the isolated DH domain fragment
of ITSN-L (residues 1229–1449) to the activity of the
bacterially expressed fragment of ITSN-L that contains the
DH domain and its COOH-terminal PH domain (residues
1229–1586, designated ITSN DH–PH) (Fig. 1). For that
purpose, we employed fluorescence spectroscopic analyses
to determine the ability of ITSN DH and ITSN DH–PH to
catalyze the incorporation of mant-GDP into bacterially
expressed GDP-preloaded proteins. We found that the
DH–PH polypeptide and the DH domain fragment dis-
played nearly identical exchange activities toward Cdc42
(Fig. 2), but not toward Rac1 or RhoA (data not shown).
These results suggest that the PH domain is dispensable for
DH domain activation, and differ from previous observa-
tions where the DH–PH domains of Trio and Dbs exhibited
greatly enhanced catalytic activities in vitro compared to
their DH domain counterparts [8,9]. Finally, the DH domain
alone retained specificity for Cdc42 and did not show
activity toward RhoA or Rac1 in vitro (data not shown).
Thus, the presence of the PH domain does not alter GEF
exchange activity or specificity in vitro.
The lack of a requirement for the PH domain for the full
catalytic function of the DH domain of ITSN-L is consistent
with our determination of the three-dimensional structure of
the ITSN DH–PH domain complexed with Cdc42, where
the PH domain does not contribute to the Cdc42 binding
interface [24]. This contrasts with the role of the PH domain
in Dbs, which does form contacts with the bound Cdc42 or
RhoA [25]. The contrasting functional and structural rela-
tionship of the PH domains with the DH domains of ITSN-L
W.M. Pruitt et al. / Biochimica et Biophysica Acta 1640 (2003) 61–68 63
and Dbs emphasizes that PH domains can exhibit very
distinct functions in different Dbl family proteins, and can
serve positive, negative, or in the case of ITSN-L, no role in
regulating the intrinsic catalytic activity of the DH domain.
3.2. The PH domain enhances ITSN-L function in vivo
Our exchange analyses in vitro indicated that the PH
domain did not serve to enhance the catalytic activity of the
DH domain (Fig. 2). However, it remains possible that the
PH domain may still contribute to DH domain function in
vivo. One approach for these analyses would be to utilize
full-length ITSN-L. However, because there is a diversity of
other protein–protein and protein–lipid interaction motifs
in sequences flanking the DH–PH domain, we were con-
cerned that any activities we observed could not be solely
ascribed to the PH domain. For example, a recent study found
that SH3A, B, and D domains of ITSN interact and inhibit a
Rac1 GAP (GTPase activating protein called CdGAP), re-
sulting in positive regulation of Rac1 activity [32], which
may indirectly affect Cdc42 activation via the DH–PH
domains. Therefore, we focused on the DH–PH fragment
and compared its activity to that of the isolated ITSN DH
domain in vivo. Our initial analyses with expression vectors
encoding these fragments did not result in significant GEF
activity in vivo. Although the proteins were expressed
adequately, their association with membranes was weak.
Moreover, we observed no differences in the localization
patterns of the DH fragment compared to the DH–PH
protein (data not shown). We reasoned that the lack of
downstream activity was most likely due to improper
membrane-targeting activity of the PH domain, which
would facilitate the DH domain interaction with its mem-
brane-bound GTPase substrates. Therefore, we decided to
generate membrane-targeted versions of ITSN DH and
ITSN DH–PH for use in these analyses.
We and others have used peptide sequences that signal
for co-translational modification of proteins by the myristate
fatty acid to target proteins to the plasma membrane [33].
Therefore, we generated expression vectors that encode NH2-
terminal myristoylation signal sequence-tagged versions of
ITSN DH and DH–PH. We first verified that the resulting
peptides were indeed associated with membranes in vivo.
NIH 3T3 cells transiently transfected with expression vec-
tors encoding these myristoylation signal sequence-tagged
peptides as well as full-length ITSN-L were subjected to
fractionation by high-speed centrifugation into crude cyto-
solic (S100) or membrane-containing particulate (P100)
fractions. Western blot analyses showed that ITSN DH
and DH–PH domains were predominantly found in the
P100 fraction, indicating that the myristoylation signal
sequence did promote consistent association with mem-
branes (Fig. 3A).
To investigate the contribution of the PH domain to
ITSN-L DH domain function in vivo, we compared the
ability of the DH and DH–PH domains to activate tran-
scription from a luciferase reporter gene expressed from a
promoter that is responsive to SRF activation. Hill et al. [34]
have previously shown that Rho GTPases are activators of
the SRF and we determined that SRF activation is also
stimulated by Dbl family proteins [35]. When expressed in
NIH 3T3 cells with the SRF reporter construct (and the h-
Fig. 2. ITSN-L DH and DH–PH domain fragments exhibit comparable
Cdc42 guanine nucleotide exchange activity in vitro. Bacterially expressed
ITSN DH (open triangles; 5 nM) and DH–PH (closed rectangles; 5 nM)
proteins were assayed for their ability to catalyze nucleotide exchange on
Cdc42 (1 AM) in vitro. Arrows indicate time at which the ITSN
polypeptides were added to the reaction mixture. The uncatalyzed reaction
(intrinsic Cdc42 exchange rate) is represented by open rectangles. Data
shown are representative of two independent experiments.
Fig. 1. Domain structure of intersectin isoforms and molecular constructs. ITSN-S and ITSN-L are alternatively spliced isoforms of a single gene. Both proteins
contain two NH2-terminal EH domains (a and b), a central a-helical coiled coil region, and five SH3 domains (A–E). ITSN-L contains additional COOH-
terminal sequences encoding tandem DH and PH domains followed by a C2 domain. Bacterial and mammalian expression vectors corresponding to the ITSN
DH and DH–PH domain fragments encode residues 1229–1449 and 1229–1586 of ITSN-L, respectively.
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galactosidase transfection control), ITSNDH stimulated SRF
activity 4-fold relative to the control empty vector (Fig. 3B).
This level of SRF activity was comparable to that observed
with the mutationally activated Cdc42(Q61L) (data not
shown), indicating that membrane targeting of the DH
domain stimulates its catalytic activity. By comparison,
the ITSN DH–PH domains caused SRF activation that
was elevated about 11-fold relative to the control vector.
The DH–PH fragment was also more potent in promoting
filopodia formation in Swiss 3T3 cells when compared to
the DH domain alone (data not shown). This difference in
activity was not due to lower levels of expression of the
Fig. 3. The PH domain enhances ITSN-L DH domain signaling activity. (A) Subcellular fractionation shows localization of membrane-targeted ITSN DH and
DH–PH domains (and Ras as a positive control), but not RhoGDI (negative control), in the particulate fraction. NIH 3T3 cells transiently transfected with 1 Ag
ITSN DH and DH–PH constructs were starved of serum for 16–18 h and cell lysates were separated into soluble (S) and particulate (P) fractions by
ultracentrifugation. Immunoblot analyses with anti-Myc, anti-RhoGDI, and anti-pan Ras antibodies were performed to detect expressed ITSN domains as well
as endogenous RhoGDI and Ras proteins, respectively. RhoGDI and Ras are exclusively localized to the cytosolic and particulate fractions, respectively,
verifying that the fractionation analyses resulted in proper separation of fractions. Data are representative of three independent experiments. (B) Membrane-
targeted versions of ITSN DH and DH–PH domains promote activation of SRF. NIH 3T3 cells were transiently co-transfected with 0.1 Ag of the pTag14-based
mammalian expression plasmid or pTag14-based plasmids encoding the DH and DH–PH fragments of ITSN, and 0.5 Ag of the luciferase gene reporter
construct for SRF transcriptional activity together with 0.2 Ag of pSPORT-h-galactosidase as a transfection control. Luciferase reporter activity and h-
galactosidase activity were measured following 16 h of serum starvation. Transfection efficiency was assessed by measuring h-galactosidase activity using the
Lumi-Gal 530 chemiluminescent assay on cell lysates as recommended by the manufacturer (Lumigen Inc., Southfield, MI). Luciferase units were normalized
over the h-galactosidase readings and the resultant expressed as fold activation relative to vector control. Error bars represent standard deviation from the mean
(S.E.) for at least three independent experiments. (C) The transient levels of ITSN DH or DH–PH fragments expressed in each cell lysate were determined by
Western blotting using anti-myc antibodies. (D) ITSN DH and DH–PH signaling is inhibited by WASP-RBD. NIH 3T3 cells were transfected as in (B) with the
indicated constructs, together with 0.5 Ag of WASP-RBD or its control vector. Luciferase activation was measured for each group and percent inhibition of SRF
activation by WASP calculated as 100[1 (RLU of WASP-transfected group/RLU of control-transfected group)]. Results are meanF S.E. of at least three
experiments performed in duplicates for each group.
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isolated DH domain compared to the DH–PH fragment
because Western blot analyses showed that the DH was
consistently expressed at approximately 2- to 3-fold higher
levels than the DH–PH fragment (Fig. 3C). Together, these
results indicate that the presence of the PH domain poten-
tiated DH domain activity in vivo. It remains possible,
however, that the PH domain may not enhance all of ITSN
functions. Such a possibility has been indicated in studies of
the Dbl family GEFs Lfc and Lbc, where the PH domain
was shown to be required for transformation, but not c-Jun
activation or stress fiber formation, respectively [35,36].
Nevertheless, our data suggest that whereas it is not essen-
tial for full DH domain catalytic function in vitro, the PH
domain appears to facilitate DH-domain-mediated signaling
events in vivo. Moreover, the Cdc42-binding domain of the
Cdc42 effector WASP (WASP-RBD) specifically blocked
ITSN DH and ITSN DH–PH function (Fig. 3D)—but not
Rac1(61L)-mediated SRF activation (data not shown)—
suggesting that ITSN DH or DH–PH variants transmit their
signals essentially through a Cdc42-dependent mechanism.
3.3. PI3K activation does not stimulate ITSN-L DH domain
function in vivo
Our phosphoinositide binding analyses argued that prod-
ucts of PI3K may not be sufficient to activate the catalytic
activity of ITSN in vitro [23]. However, it remains signifi-
cantly possible that association of PtdIns(3,4,5)P3 with the
PH domain may modulate ITSN-L DH domain activity in
vivo as has been shown for Vav, Sos1, and Tiam1 Dbl
family proteins [10,11,37]. To address this possibility, we
determined if co-expression of a constitutively activated
variant of PI3K (p110-CAAX; a membrane-targeted variant
of the p110 catalytic subunit of PI3K) could potentiate ITSN
DH–PH signaling activity. As shown in Fig. 4A, expression
of either p110-CAAX or ITSN DH–PH alone caused a 5-
fold stimulation of SRF activity. Surprisingly, co-expression
of p110-CAAX with ITSN DH–PH caused about 2-fold
enhancement in SRF activation, suggesting an additive
effect of ITSN DH–PH and PI3K. This finding indicates
that PI3K activation does not modulate ITSN-L DH domain
catalytic activity in vivo. To directly evaluate this lack of
synergism, we determined the effect of p110-CAAX co-
expression on ITSN DH–PH-mediated stimulation of the
formation of active GTP-bound Cdc42. For these analyses,
we used a GST fusion protein containing the Cdc42 binding
domain of the Cdc42 effector PAK (designated GST:PAK
RBD) in a pull-down assay for Cdc42-GTP. Expression of
ITSN DH–PH alone promoted the formation of Cdc42-GTP
(Fig. 4B). Interestingly, co-expression of the activated PI3K
subunit with ITSN DH–PH failed to cause further increase
in Cdc42-GTP levels. Thus, PI3K activation does not
cooperate with ITSN DH–PH in promoting increased
downstream signaling.
The role of PI3K activation in regulating DH domain
function is best characterized for Vav. Han et al. [11]
previously determined that substrates of PI3K inhibited the
catalytic activity of Vav, whereas products of PI3K sti-
mulated this activity in vitro. Recently, they determined
that substrates of PI3K promoted the interaction of the PH
domain with the DH domain and prevented Rho GTPase
binding to the DH domain, whereas products of PI3K
disrupted this interaction and permitted GTPase binding
[38]. Thus, PtdIns(3,4,5)P3 association with the PH domain
Fig. 4. Lipid second messengers do not potentiate ITSN-L DH–PH domain catalytic activity in vivo. (A) Co-expression of activated PI3K (p110-CAAX) does
not cooperate with ITSN DH–PH in activation of SRF. NIH 3T3 cells were transiently co-transfected with the membrane-targeting ITSN plasmids (pTag; 0.05
Ag) and the SRF-luciferase gene reporter plasmid (0.5 Ag) as described in Fig. 3B, with 0.5 Ag of pZIP-NeoSV( )1 expression plasmid or pZIP-NeoSV( )1
encoding the 110-kDa catalytic subunit of PI3K fused to the plasma-membrane-targeting CAAX tetrapeptide motif (activated PI3K). Luciferase reporter
activity was measured following 16 h of serum starvation in 0.5% calf serum. Data shown are representative of at least three independent experiments
performed on duplicate dishes. Error bars = S.E. (B) Co-expression of activated PI3K with ITSN DH–PH has little to no effect on DH-domain-stimulated
formation of active Cdc42-GTP. Lysates of NIH 3T3 cells expressing ITSN DH–PH with and without the activated p110-CAAX expression plasmid were
incubated with Pak-RBD bound to glutathione beads. Endogenous Cdc42-GTP complexed with Pak-RBD was visualized by immunoblot analyses with an anti-
Cdc42 monoclonal antibody (see Materials and methods). Data are representative of three independent experiments.
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is thought to modulate DH domain catalytic activity. How-
ever, because the critical structural determinants required for
high-affinity binding to phosphoinositides are absent from
the PH domains of Dbl family proteins [12,13], we ques-
tioned whether this mechanism of regulation will be
extended to other Dbl family members. Our recent in vitro
analyses, where we found that the catalytic activity of ITSN
DH–PH was not stimulated by phosphoinositide interac-
tions, argued against such a role [23]. Similar negative
results were also seen with the DH–PH fragments of Tiam1
and Dbs. However, because these analyses were done under
in vitro conditions, in the present study, we evaluated wheth-
er PI3K activation was involved in PH domain regulation of
DH domain function in vivo. We found only an additive
stimulation of ITSN-L DH domain-mediated signaling and
formation of Cdc42-GTP in vivo. Thus, we suggest that
PI3K is not a significant regulator of DH domain function for
ITSN-L in cells.
In summary, our observations with the PH domain of
ITSN-L highlight the diverse functions that this domain may
serve in regulating the function of adjacent DH domains.
Thus, while the majority of PH domains are invariantly
positioned COOH-terminal to all DH domains, their roles in
regulation of DH domain function are not invariant and may
range from a positive to negative role in activation of Rho
GTPases. Finally, although earlier studies supported an
important role for PI3K activation in regulation of Dbl
family protein function, the results from this study and
others argue against such a role for at least a growing subset
of Dbl family proteins.
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